EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17634939

Download in:

View as

General Info

PMID
17634939